Illumina Inc (ILMN)

263.50 -9.49  -3.48% NASDAQ Apr 3, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
04/24/2020 14:00 PDT Misc Illumina Inc First Quarter Earnings Conference Call in 2020
04/24/2020 Earnings Illumina Inc First Quarter Earnings in 2020 Release
02/11/2020 Misc Illumina Inc Annual Report for 2019
01/29/2020 17:00 EST Misc Illumina Inc Fourth Quarter Earnings Conference Call for 2019
01/29/2020 Earnings Illumina Inc Fourth Quarter Earnings in 2019 Release
10/24/2019 14:00 PDT Misc Illumina Inc Third Quarter Earnings Conference Call for 2019
10/24/2019 Earnings Illumina Inc Third Quarter Earnings in 2019 Release
07/29/2019 17:00 EDT Misc Illumina Inc Second Quarter Earnings Conference Call in 2019
07/29/2019 Earnings Illumina Inc Second Quarter Earnings in 2019 Release
05/29/2019 10:00 PDT Misc Illumina Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.illumina.com
  • Investor Relations URL: http://www.illumina.com/company/investor-information.html
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Apr. 24, 2020
  • Last Earnings Release: Jan. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (73% of 2019 sales). Illumina‚Äôs high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 17% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

Top Fund Holders

Symbol Name Weighting
ARKG ARK Genomic Revolution ETF 8.85%
ARKK ARK Innovation ETF 6.43%
IBB iShares Nasdaq Biotechnology ETF 5.42%
MSHLX Morgan Stanley Inst Growth L 5.12%
EGFFX Edgewood Growth Retail 4.51%
HQH Tekla Healthcare Investors 4.30%
FBT First Trust NYSE Arca Biotech ETF 3.17%
ZCG.TO BMO Concentrated Global Equity ETF Ser 2.78%
VWIGX Vanguard International Growth Inv 2.20%
VAFNX Invesco American Franchise R5 1.75%
VWUSX Vanguard US Growth Investor 1.59%
HRCAX Harbor Capital Appreciation Admin 1.44%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.